These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2952499)

  • 1. Comparative in vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
    Hodinka RL; Jack-Wait K; Gilligan PH
    Eur J Clin Microbiol; 1987 Feb; 6(1):103-8. PubMed ID: 2952499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.
    Eliopoulos GM; Reiszner E; Ferraro MJ; Moellering RC
    J Antimicrob Chemother; 1987 Nov; 20(5):671-5. PubMed ID: 2962974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV; Shayegani M
    J Antimicrob Chemother; 1988 May; 21(5):565-70. PubMed ID: 2968968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of A-56268 (TE-031), a new macrolide antibiotic, compared with that of erythromycin and other antimicrobial agents.
    Floyd-Reising S; Hindler JA; Young LS
    Antimicrob Agents Chemother; 1987 Apr; 31(4):640-2. PubMed ID: 2955742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of A-56268.
    Sefton AM; Maskell JP; Yong FJ; Chi SJ; Williams JD
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):798-802. PubMed ID: 2975218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
    Maskell JP; Sefton AM; Williams JD
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents.
    King A; Phillips I
    J Hosp Infect; 1991 Sep; 19 Suppl A():3-9. PubMed ID: 1684981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
    Benson C; Segreti J; Kessler H; Hines D; Goodman L; Kaplan R; Trenholme G
    Eur J Clin Microbiol; 1987 Apr; 6(2):173-8. PubMed ID: 2954818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.
    Barlam T; Neu HC
    Antimicrob Agents Chemother; 1984 Apr; 25(4):529-31. PubMed ID: 6732223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
    Maskell JP; Sefton AM; Yong J; Chi SJ; Williams JD
    Infection; 1988; 16(6):365-70. PubMed ID: 3146552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
    Westerman EL; Williams TW; Moreland N
    Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of LY281389 and comparison with erythromycin and oral beta-lactams.
    Qadri SM; Ueno Y; Frayha HH
    Chemotherapy; 1991; 37(4):270-4. PubMed ID: 1790725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
    Rolston KV; Ho DH; LeBlanc B; Bodey GP
    Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):30-3. PubMed ID: 2137413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of ABT-773 and two macrolides against staphylococci.
    von Eiff C; Peters G
    J Antimicrob Chemother; 2002 Jan; 49(1):189-92. PubMed ID: 11751787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of the new oral macrolide azithromycin.
    Neu HC; Chin NX; Saha G; Labthavikul P
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):541-4. PubMed ID: 2846300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of clarithromycin, a new macrolide antibiotic, and regression curve].
    Soussy CJ; Le Van Thoi J; Cluzel M; Derlot E; Kitzis MD
    Pathol Biol (Paris); 1990 May; 38(5):401-6. PubMed ID: 2142274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.